{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:57:44Z","timestamp":1785326264503,"version":"3.55.0"},"reference-count":30,"publisher":"Society of Nuclear Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,5]]},"DOI":"10.2967\/jnumed.124.268901","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:40:42Z","timestamp":1743147642000},"page":"713-718","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [<sup>68<\/sup>Ga]Ga-PSMA-11 PET\/CT in the proPSMA Study"],"prefix":"10.2967","volume":"66","author":[{"given":"David C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Buteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Emmett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"de Galiza Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"McVey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn J.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"2025050105251680000_66.5.713.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7"},{"key":"2025050105251680000_66.5.713.2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on Prostate Cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet."},{"key":"2025050105251680000_66.5.713.3","unstructured":"Prostate cancer. EAU website. https:\/\/uroweb.org\/guidelines\/prostate-cancer. Accessed February 25, 2025."},{"key":"2025050105251680000_66.5.713.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.195172"},{"key":"2025050105251680000_66.5.713.5","doi-asserted-by":"crossref","unstructured":"Vetrone L Mei R Bianchi L . Histology and PSMA expression on immunohistochemistry in high-risk prostate cancer patients: comparison with 68Ga-PSMA PET\/CT features in primary staging. Cancers (Basel). 2023;15:1716.","DOI":"10.3390\/cancers15061716"},{"key":"2025050105251680000_66.5.713.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169243"},{"key":"2025050105251680000_66.5.713.7","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00259-022-05756-2","article-title":"Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy","volume":"49","author":"Roberts","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025050105251680000_66.5.713.8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00259-020-04944-2","article-title":"68Ga-PSMA PET\/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer","volume":"48","author":"Roberts","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025050105251680000_66.5.713.9","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res."},{"key":"2025050105251680000_66.5.713.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3631-6"},{"key":"2025050105251680000_66.5.713.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.002"},{"key":"2025050105251680000_66.5.713.12","doi-asserted-by":"crossref","unstructured":"Chen DC Huang S Papa N . Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta\u2010analysis. BJU Int. January 7, 2025 [Epub ahead of print].","DOI":"10.1111\/bju.16608"},{"key":"2025050105251680000_66.5.713.13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41391-023-00759-y","article-title":"High GLUT1 membrane expression and low PSMA membrane expression in ductal adenocarcinoma and intraductal carcinoma of the prostate","volume":"27","author":"Wang","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2025050105251680000_66.5.713.14","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025050105251680000_66.5.713.15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"2025050105251680000_66.5.713.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263448"},{"key":"2025050105251680000_66.5.713.17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bju.15664","article-title":"The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography\/computed tomography","volume":"129","author":"Veerman","year":"2022","journal-title":"BJU Int."},{"key":"2025050105251680000_66.5.713.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05831-8"},{"key":"2025050105251680000_66.5.713.19","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.7150\/thno.44584","article-title":"Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11-PET","volume":"10","author":"Ferraro","year":"2020","journal-title":"Theranostics."},{"key":"2025050105251680000_66.5.713.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05501-1"},{"key":"2025050105251680000_66.5.713.21","doi-asserted-by":"crossref","unstructured":"Rosenzweig B Haramaty R Davidson T . Very low prostate PET\/CT PSMA uptake may be misleading in staging radical prostatectomy candidates. J Pers Med. 2022;12:410.","DOI":"10.3390\/jpm12030410"},{"key":"2025050105251680000_66.5.713.22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/bju.14374","article-title":"A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET\/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol","volume":"122","author":"Hofman","year":"2018","journal-title":"BJU Int."},{"key":"2025050105251680000_66.5.713.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.202861"},{"key":"2025050105251680000_66.5.713.24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bju.14794","article-title":"Diagnostic accuracy of 68Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68Ga-PSMA PET to mpMRI","volume":"124","author":"Scheltema","year":"2019","journal-title":"BJU Int."},{"key":"2025050105251680000_66.5.713.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2016.07.004"},{"key":"2025050105251680000_66.5.713.26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1544208"},{"key":"2025050105251680000_66.5.713.27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/bju.15896","article-title":"The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography\/computed tomography","volume":"130","author":"Veerman","year":"2022","journal-title":"BJU Int."},{"key":"2025050105251680000_66.5.713.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035774"},{"key":"2025050105251680000_66.5.713.29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41391-024-00818-y","article-title":"MDT perspective: intraductal carcinoma of the prostate: implication for diagnosis and treatment","volume":"27","author":"Zeng","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2025050105251680000_66.5.713.30","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24291"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:25:49Z","timestamp":1746102349000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,1]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.2967\/jnumed.124.268901"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268901","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}